Methylphenidate (Ritalin) is a psychostimulant drug approved for treatment of ADHD or attention-deficit hyperactivity disorder, postural orthostatic tachycardia syndrome and narcolepsy. The original patent was owned by CIBA, now Novartis Corporation). It was first licensed by the FDA in 1955 for treating ADHD, prescribed from 1960, and became heavily prescribed in the 1990s, when the diagnosis of ADHD itself became more widely accepted.
You may also like
About the author
Information to enrich your life.
WELCOME TO RICHTOPIA
- 2,429,697 all-time users
- 11 Amazing Examples of Disruptive Technology
- Africa Exclusive: Property Investment in Lagos, Nigeria
- Review of the 6 Major Blockchain Protocols
- What Is Social Marketing? And How Does It Work?
- 7 Wealth Habits of the World’s Richest People
- Five Fundamental Principles From Adam Grant's "Give and Take" Book
- 17 Great Examples of Effective Leadership and Strategy
- Workplace Culture: How to Encourage Collaboration
- Top 20 Blockchain Books & Whitepapers